Normalized endothelial function but sustained cardiovascular risk profile 11 years following a pregnancy complicated by preeclampsia

Hypertension Research

Volumn 36, Issue 12, 2013, Pages 1081-1087

  Östlund, Eva ^a   Al Nashi, Maha ^b   Hamad, Rangeen Rafik ^b   Larsson, Anders ^c   Eriksson, Maria ^d   Bremme, Katarina ^b   Kahan, Thomas ^a  

^a DANDERYD HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

arterial function; blood pressure; cardiovascular disease; endothelial function; preeclampsia

Indexed keywords

ALBUMIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; CATHEPSIN B; CATHEPSIN S; CREATININE; HOMOCYSTEINE; INTERCELLULAR ADHESION MOLECULE 1; PENTRAXIN 3; PLACENTAL GROWTH FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN RECEPTOR 1;

ADULT; ARTERIAL STIFFNESS; ARTICLE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENDOTHELIAL DYSFUNCTION; FEMALE; FLOW MEDIATED DILATATION; FOLLOW UP; FOREARM BLOOD FLOW; GLUCOSE METABOLISM; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; LEUKOCYTE COUNT; LIPID METABOLISM; MEDICAL HISTORY; PREECLAMPSIA; PREGNANCY COMPLICATION; PROVOCATION TEST; PULSE WAVE; SYSTOLIC BLOOD PRESSURE; VASCULAR ENDOTHELIUM;

ADRENERGIC BETA-2 RECEPTOR AGONISTS; ADULT; AGE FACTORS; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; FEMALE; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; HEART RATE; HUMANS; HYPEREMIA; LIPID METABOLISM; LONGITUDINAL STUDIES; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PRE-ECLAMPSIA; PREGNANCY; PULSE WAVE ANALYSIS; RISK ASSESSMENT; RISK FACTORS; VASODILATION;

EID: 84890029446     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2013.81     Document Type: Article

References (40)

1. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: Systematic review and meta-Analysis. BMJ 2007; 335: 974
2. McDonald SD, Malinowski A, Zhou Q, Devereaux PJ. Cardiovascular sequelae of preeclampsia/eclampsia: A systematic review and meta-Analyses. Am Heart J 2008; 156: 918-930
3. Lykke JA, Langhoff-Roos J, Sibai BM, Funai EF, Triche EW, Paidas MJ. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes in the mother. Hypertension 2009; 53: 944-951
4. Hamad RR, Eriksson MJ, Silveira A, Hamsten A, Bremme K. Decreased flow-mediated dilation is present 1 year after a pre-eclamptic pregnancy. J Hypertens 2007; 25: 2301-2307
5. Romundstad PR, Magnussen EB, Smith GD, Vatten LJ. Hypertension in pregnancy and later cardiovascular risk: Common antecedents? Circulation 2010; 122: 579-584
6. Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstetr Gynecol 1988; 158: 892-898
7. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I, Struijker-Boudier H, European Network for Non-invasive Investigation of Large Arteries. Expert consensus document on arterial stiffness: Methodological issues and clinical applications. Eur Heart J 2006; 21: 2588-2605
8. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R, International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39: 257-265
9. Wilkinson IB, Hall IR, MacCallum H, Mackenzie IS, McEniery CM, Van DerArend BJ, Shu YE, MacKay LS, Webb DJ, Cockcroft Jr. Pulse-waveanalysis: Clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function. Arterioscler Thromb Vasc Biol 2002; 22: 147-152
10. Lind L, Fors N, Hall J, Marttala K, Stenborg A. A comparison of three different methods to evaluate endothelium-dependent vasodilation in the elderly: The Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Arterioscler Thromb Vasc Biol 2005; 25: 2368-2375
11. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419
12. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ. Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85: 2402-2410
13. Nordén Lindeberg S, Hanson U. Hypertension and factors associated with metabolic syndrome at follow-up at 15 years in women with hypertensive disease during first pregnancy. Hypertens Pregnancy 2000; 19: 191-198
14. Mangos GJ, Spaan JJ, Pirabhahar S, Brown MA. Markers of cardiovascular disease risk after hypertension in pregnancy. J Hypertens 2012; 30: 351-358
15. Hansen TW, Li Y, Boggia J, Thijs L, Richart T, Staessen J. Predictive role of the nighttime blood pressure. Hypertension 2011; 57: 3-10
16. Chen X, Wang Y. Tracking of blood pressure from childhood to adulthood: A systematic review and meta-regression analysis. Circulation 2008; 117: 3171-3180
17. Conen D, Tedrow UB, Koplan BA, Glynn RJ, Buring JE, Albert CM. Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women. Circulation 2009; 119: 2146-2152
18. Sundström J, Neovius M, Tynelius P, Rasmussen F. Association of blood pressure in late adolescence with subsequent mortality: Cohort study of Swedish male conscripts. BMJ 2011; 22: D643
19. Hausvater A, Giannone T, Sandoval YH, Doonan RJ, Antonopoulos CN, Matsoukis IL, Petridou ET, Daskalopoulou SS. The association between preeclampsia and arterial stiffness. J Hypertens 2012; 30: 17-33
20. Evans CS, Gooch L, Flotta D, Lykins D, Powers RW, Landsittel D, Roberts JM, Shroff SG. Cardiovascular system during the postpartum state in women with a history of preeclampsia. Hypertension 2011; 58: 57-62
21. Rönnbäck M, Lampinen K, Groop PH, Kaaja R. Pulse wave reflection in currently and previously preeclamptic women. Hypertens Pregnancy 2005; 24: 171-180
22. Lampinen KH, Rönnbäck M, Kaaja RJ, Groop PH. Impaired vascular dilatation in women with a history of pre-eclampsia. J Hypertens 2006; 4: 751-756
23. Pàez O, Alfie J, Gorosito M, Puleio P, de Maria M, Prieto N, Majul C. Parallel decrease in arterial distensibility and endothelium-dependant dilatation in young women with a history if pre-eclampsia. Clin Exp Hypertens 2009; 31: 544-552
24. Yinon Y, Kingdom JCP, Odutayo A, Moineddin R, Drewlo S, Lai V, Cherney DZI, Hlasunewich MA. Vascular dysfunction in women with a history of preeclampsia and intrauterine growth restriction. Circulation 2010; 122: 1846-1853
25. Spaan J, Houben A, Musella A, Ekhart T, Spanderman M, Peeters L. Insulin resistance relates to microvascular reactivity 23 years after preeclampsia. Microvasc Res 2010; 80: 417-421
26. Chambers JC, Fusi L, Malik IS, Haskard DO, De Swiet M, Kooner JS. Association of maternal endothelial dysfunction with preeclampsia. JAMA 2001; 285: 1607-1612
27. Germain AM, Romanik MC, Guerra I, Solari S, Reyes MS, Johnson RJ, Price K, Karumanchi SA, Valdés G, Mitchell GF. Endothelial dysfunction: A link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events? Hypertension 2007; 49: 90-95
28. Kvehaugen AS, Dechend R, Ramstad HB, Troisi R, Fugelseth D, Staff AC. Endothelial function and circulating biomarkers are disturbed in women and children after preeclampsia. Hypertension 2011; 58: 63-69
29. Mitchell GF, Parise H, Vita JA, Larson MG, Warner E, Keaney JF Jr, Keyes MJ, Levy D, Vasan RS, Benjamin EJ. Local shear stress and brachial artery flow-mediated dilation: The Framingham Heart Study. Hypertension 2004; 44: 134-139
30. Järhult SJ, Hall J, Lind L. Hyperaemic blood-flow velocities in systole and diastole relate to coronary risk in divergent ways. Clin Physiol Funct Imaging 2008; 28: 189-195
31. Järhult SJ, Sundström J, Lind L. Brachial artery hyperemic blood flow velocities are related to carotid atherosclerosis. Clin Physiol Funct Imaging 2009; 29: 360-365
32. Souwer ET, Blaauw J, Coffeng SM, Smit AJ, Van Doormaal JJ, Faas MM, Van Pampus MG. Decreased arterial elasticity in formerly early-onset preeclamptic women. Acta Obstet Gynecol Scand 2011; 90: 797-801
33. Sattar N, Ramsay J, Crawford L, Cheyne H, Greer IA. Classic and novel risk factor parameters in women with a history of preeclampsia. Hypertension 2003; 42: 39-42
34. Gaugler-Senden IP, Tamsma JT, Van Der Bent C, Kusters R, Steegers EA, de Groot CJ. Angiogenic factors in women ten years after severe very early-onset preeclampsia. PLoS One 2012; 7: E43637
35. Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, Curhan GC, Rifai N, Cannuscio CC, Stampfer MJ, Rimm EB. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 2004; 351: 2599-2610
36. Vitoratos N, Economou E, Iavazzo C, Panoulis K, Creatsas G. Maternal serum levels of TNF-Alpha and IL-6 long after delivery in preeclamptic and normotensive pregnant women. Mediator Inflamm 2010; 2010: 908649
37. Freeman DJ, McManus F, Brown EA, Cherry L, Norrie J, Ramsay JE, Clark P, Walker ID, Sattar N, Greer IA. Short-And long-Term changes in plasma inflammatory markers associated with preeclampsia. Hypertension 2004; 44: 708-714
38. Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GD, Fowkes FG. C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study. Circulation 2005; 112: 976-983
39. Van Der Meer IM, de Maat MP, Bots ML, Breteler MM, Meijer J, Kiliaan AJ, Hofman A, Witteman JC. Inflammatory mediators and cell adhesion molecules as indicators of severity of atherosclerosis: The Rotterdam Study. Artherioscler Thromb Vasc Biol 2002; 22: 838-842
40. Spaan J, Peeters L, Spaanderman M, Brown M. Cardiovascular risk management after a hypertensive disorder of pregnancy. Hypertension 2012; 60: 1368-1373